Wells Fargo & Company MN Sells 126,763 Shares of Cantel Medical Corp. (CMD)

Wells Fargo & Company MN cut its stake in shares of Cantel Medical Corp. (NYSE:CMD) by 13.0% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 845,062 shares of the company’s stock after selling 126,763 shares during the period. Wells Fargo & Company MN owned approximately 2.03% of Cantel Medical worth $79,580,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. First Trust Advisors LP lifted its position in Cantel Medical by 6.8% during the 3rd quarter. First Trust Advisors LP now owns 11,677 shares of the company’s stock worth $1,100,000 after acquiring an additional 739 shares in the last quarter. Rhumbline Advisers increased its holdings in Cantel Medical by 1.2% during the 3rd quarter. Rhumbline Advisers now owns 76,496 shares of the company’s stock worth $7,204,000 after purchasing an additional 870 shares during the last quarter. Aperio Group LLC increased its holdings in Cantel Medical by 8.4% during the 3rd quarter. Aperio Group LLC now owns 13,894 shares of the company’s stock worth $1,308,000 after purchasing an additional 1,075 shares during the last quarter. Globeflex Capital L P purchased a new stake in Cantel Medical during the 2nd quarter worth approximately $114,000. Finally, American International Group Inc. increased its holdings in Cantel Medical by 5.4% during the 3rd quarter. American International Group Inc. now owns 28,684 shares of the company’s stock worth $2,701,000 after purchasing an additional 1,464 shares during the last quarter. 84.98% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Cantel Medical Corp. (NYSE:CMD) traded down $2.89 during midday trading on Wednesday, hitting $100.49. The stock had a trading volume of 208,500 shares, compared to its average volume of 146,027. Cantel Medical Corp. has a 1-year low of $69.21 and a 1-year high of $108.00. The company has a quick ratio of 1.49, a current ratio of 2.41 and a debt-to-equity ratio of 0.24. The company has a market cap of $4,321.89, a P/E ratio of 49.70 and a beta of 1.24.

Cantel Medical (NYSE:CMD) last issued its quarterly earnings data on Thursday, September 28th. The company reported $0.54 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.02. The firm had revenue of $205.50 million during the quarter, compared to the consensus estimate of $200.32 million. Cantel Medical had a return on equity of 17.60% and a net margin of 9.27%. Cantel Medical’s revenue was up 14.8% on a year-over-year basis. research analysts forecast that Cantel Medical Corp. will post 2.34 EPS for the current year.

The firm also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Wednesday, January 17th will be given a dividend of $0.085 per share. This represents a yield of 0.17%. The ex-dividend date is Tuesday, January 16th. This is a positive change from Cantel Medical’s previous Semi-Annual dividend of $0.07. Cantel Medical’s payout ratio is 8.19%.

A number of equities research analysts have recently weighed in on CMD shares. Needham & Company LLC reiterated a “hold” rating on shares of Cantel Medical in a report on Friday, September 1st. Zacks Investment Research upgraded Cantel Medical from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $91.67.

In other Cantel Medical news, Director Mark N. Diker sold 7,000 shares of the business’s stock in a transaction on Tuesday, October 3rd. The stock was sold at an average price of $98.90, for a total transaction of $692,300.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Eric W. Nodiff sold 2,868 shares of the business’s stock in a transaction on Friday, October 20th. The stock was sold at an average price of $97.55, for a total value of $279,773.40. Following the transaction, the executive vice president now owns 39,102 shares of the company’s stock, valued at approximately $3,814,400.10. The disclosure for this sale can be found here. Insiders have sold a total of 36,368 shares of company stock valued at $3,576,028 in the last quarter. 12.30% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: “Wells Fargo & Company MN Sells 126,763 Shares of Cantel Medical Corp. (CMD)” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.chaffeybreeze.com/2017/12/06/wells-fargo-company-mn-sells-126763-shares-of-cantel-medical-corp-cmd.html.

Cantel Medical Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Institutional Ownership by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply